Novo Nordisk Gets US Approval for Wegovy Obesity Pill
December 23, 2025
28 min
Full
3,285 of 3,435
December 23, 2025
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
0:00 / 28:56
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Bloomberg Podcasts Episodes Around December 23, 2025
Episode 3,285 of 3,435 — walk the feed in the order it was published.
28:56This episodeNovo Nordisk Gets US Approval for Wegovy Obesity Pill
Summary
<p>Watch Scarlet and Paul LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p> <p>Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu<br /><br />- John Tozzi, Bloomberg Health Care Reporter, discusses Novo Nordisk winning approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term.</p> <p>- Reshmi Basu, Bloomberg News Credit Reporter, discusses Saks Global Enterprises, facing limited options ahead of a more than $100 million debt payment due at the end of this month, considering Chapter 11 bankruptcy.<br /><br />-George Ferguson, Bloomberg Intelligence Senior Aerospace, Defense, & Airlines Analyst, talks about his outlook for North Americans airlines in 2026.<br /> <br />- Nathan Dean, Bloomberg Intelligence Senior Policy Analyst, breaks down the 2025 "Winners & Losers"</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.